Thane, Mar 20: A 39-year-old man who initially presented with severe anaemia was diagnosed with rectosigmoid colon cancer that had unusually spread to his thyroid gland — a rare site for metastasis in colorectal malignancies. After comprehensive treatment at KIMS Hospitals, Thane, including dual surgeries and adjuvant chemotherapy, the patient is now disease-free on follow-up Positron Emission Tomography (PET) scan.
The patient first approached doctors after routine blood tests revealed significantly low haemoglobin levels. Further evaluation, including colonoscopy and imaging, identified a tumour in the rectosigmoid region — the junction between the rectum and sigmoid colon. As part of complete cancer staging to determine disease spread, imaging also revealed a suspicious thyroid nodule. Fine Needle Aspiration Cytology (FNAC) suggested malignancy, raising concern for either a second primary cancer or metastatic disease.
Given the dual findings, the patient underwent total thyroidectomy (complete removal of the thyroid gland), followed by anterior resection with primary anastomosis — a surgery in which the cancerous segment of the colon is removed and the healthy bowel ends are reconnected in the same procedure. He had good postoperative recovery
However, post-operative histopathological analysis revealed an unexpected result: the thyroid lesion was not a separate cancer but an isolated metastasis originating from the colon tumour. This finding changed the diagnosis to Stage IV colorectal cancer.
“Metastasis from colon cancer to the thyroid gland is extremely uncommon,” said Dr Saneya Pandrowala, Consultant GI and HPB (Hepato-Pancreato-Biliary) Oncosurgery at KIMS Hospitals, Thane. “What made this case particularly unique was that the thyroid was the only distant organ involved. With aggressive surgical management and timely systemic therapy, selected Stage IV cancers can still be treated with curative intent.”
Following surgery, the patient completed adjuvant chemotherapy under oncological supervision. On subsequent follow-up, his PET scan showed no evidence of residual or recurrent disease.
Doctors emphasised that this case highlights the importance of meticulous staging, multidisciplinary tumour board discussions, and coordinated surgical and medical oncology care. It also reinforces an evolving reality in cancer treatment — that even certain Stage IV cancers, when limited and strategically managed, can achieve long-term remission
